Wei-xing H. Guo

225 Changhai Road
Shanghai, 200438, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.

Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.

Journal: The oncologist

Published: December 01, 2025

Efficacy and Safety of a Simple Auxiliary Liver Suspension Device in Complex Laparoscopic Hepatectomy: A Multicenter Randomized Clinical Trial.

Efficacy and Safety of a Simple Auxiliary Liver Suspension Device in Complex Laparoscopic Hepatectomy: A Multicenter Randomized Clinical Trial.

Journal: Annals of gastroenterological surgery

Published: November 10, 2025

Development of a new nomogram for predicting recurrence in HCC with MVI following curative hepatectomy.

Development of a new nomogram for predicting recurrence in HCC with MVI following curative hepatectomy.

Journal: International journal of surgery (London, England)

Published: June 16, 2025

Development of a new nomogram for predicting recurrence in HCC With MVI following curative hepatectomy.

Development of a new nomogram for predicting recurrence in HCC With MVI following curative hepatectomy.

Journal: International journal of surgery (London, England)

Published: June 16, 2025

Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).

Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).

Journal: Liver cancer

Published: January 31, 2024

Effects of electroacupuncture on the glucose-lipid metabolism and the expression of ZAG and GLUT4 in the femoral quadriceps and adipose tissue in the rats with type 2 diabetes mellitus.

Effects of electroacupuncture on the glucose-lipid metabolism and the expression of ZAG and GLUT4 in the femoral quadriceps and adipose tissue in the rats with type 2 diabetes mellitus.

Journal: Zhongguo zhen jiu = Chinese acupuncture & moxibustion

Published: December 13, 2023

Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody.

Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody.

Journal: The oncologist

Published: October 04, 2023

A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension.

A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension.

Journal: BMC cancer

Published: September 26, 2023

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

Journal: Nature medicine

Published: September 20, 2023

Short-term and long-term outcomes after robotic versus open hepatectomy in patients with large hepatocellular carcinoma: a multicenter study.

Short-term and long-term outcomes after robotic versus open hepatectomy in patients with large hepatocellular carcinoma: a multicenter study.

Journal: International journal of surgery (London, England)

Published: July 20, 2023

Effect of electroacupuncture on liver Akt/FoxO1 signaling pathway in rats with diabetic fatty

Effect of electroacupuncture on liver Akt/FoxO1 signaling pathway in rats with diabetic fatty

Journal: Zhongguo zhen jiu = Chinese acupuncture & moxibustion

Published: June 14, 2023

Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial.

Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial.

Journal: Future oncology (London, England)

Published: May 03, 2023

Showing 1-12 of 64

Last Updated: 09/26/2026